Mometasone furoate nasal spray increases the number of minimal-symptom days in patients with acute rhinosinusitis
Authors:
- Eli O. MeltzerEMEli O. Meltzer
- Davis GatesDGDavis Gates
- Claus BachertCBClaus Bachert
- 1 April 2012
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 108 (4) , 275-279
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effectiveness of Mometasone Furoate Nasal Spray with or without Antibiotics vs. Antibiotic Monotherapy in Patients with Acute Rhinosinusitis in the United KingdomJournal of Allergy and Clinical Immunology, 2011
- Steroids for acute sinusitis2007
- Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placeboJournal of Allergy and Clinical Immunology, 2005
- Otolaryngology‐Head and Neck SurgeryOtolaryngology–Head and Neck Surgery, 2004
- Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitisAnnals of Allergy, Asthma & Immunology, 2002
- Comparison of Cefuroxime With or Without Intranasal Fluticasone for the Treatment of RhinosinusitisThe CAFFS Trial: A Randomized Controlled TrialJAMA, 2001
- Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal sprayJournal of Allergy and Clinical Immunology, 2000
- The common cold: Effects of intranasal fluticasone propionate treatment☆☆☆★★★Journal of Allergy and Clinical Immunology, 1998
- Intranasal Budesonide Spray as an Adjunct to Oral Antibiotic Therapy for Acute Sinusitis in ChildrenAnnals of Allergy, Asthma & Immunology, 1997
- A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal sprayJournal of Allergy and Clinical Immunology, 1996